Traumatic brain injury (TBI) carries consequences that can last a lifetime, from permanently impaired cognition and memory to increased risk of Alzheimer’s disease and other forms of dementia.
Although surgery and behavioral rehabilitation can help patients cope with ongoing symptoms, no pharmacological therapies currently exist. Researchers report that TBI causes the integrated stress response (ISR) signaling pathway to remain persistently activated in the hippocampus, a brain region implicated in memory and learning.
Furthermore, the authors demonstrate that a small molecule called ISR inhibitor (ISRIB) inhibits the core event of ISR and restores cognitive deficits in mice. Common to all eukaryotic cells, ISR acts to restore cellular homeostasis by phosphorylating eukaryotic translation initiation factor 2 (eIF2α).
Due to its small size, ISRIB readily crosses the blood–brain barrier and blunts the restoration. To determine whether sustained hippocampal eIF2α phosphorylation underpins the long-term symptoms of TBI, the authors conducted trials with two different murine models and found that ISRIB treatment is sufficient to reverse hippocampus-dependent cognitive deficits.
In addition, systemic ISRIB treatment weeks after injury enabled mice to form stable spatial memories that persisted at least 1 week after treatment stopped. Though preliminary, the findings point to a potential therapeutic path for TBI, according to the authors.
http://www.pnas.org/content/early/2017/07/05/1707661114
Latest News
TB blood test which could d…
By newseditor
Posted 27 Mar
Propionate supplementation…
By newseditor
Posted 27 Mar
Role of human Kallistatin i…
By newseditor
Posted 26 Mar
Addressing both flu and COV…
By newseditor
Posted 26 Mar
How the brain senses body p…
By newseditor
Posted 26 Mar
Other Top Stories
Predicting fruit fly stripe formation during embryonic development
Read more
Extending lifespan of mice with CRISPR-CAS9 gene therapy
Read more
Gene therapy for congenital deafness
Read more
Gene variants that significantly influence how the body distributes…
Read more
A microRNA mutation results in skeletal muscle disease!
Read more
Protocols
All-optical presynaptic pla…
By newseditor
Posted 23 Mar
Epigenomic tomography for p…
By newseditor
Posted 20 Mar
A mouse DRG genetic toolkit…
By newseditor
Posted 17 Mar
An optogenetic method for t…
By newseditor
Posted 13 Mar
Profiling native pulmonary…
By newseditor
Posted 08 Mar
Publications
Integrated plasma proteomic…
By newseditor
Posted 27 Mar
APP antisense oligonucleoti…
By newseditor
Posted 27 Mar
Targeting Erbin-mitochondri…
By newseditor
Posted 27 Mar
Regulation of Zbp1 by miR-9…
By newseditor
Posted 27 Mar
Pain-free oral delivery of…
By newseditor
Posted 27 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar